Pharmaceuticals in Europe - Research and Markets

Pharmaceuticals in Europe industry profile provides top-line qualitative and quantitative summary information including: market size (value 2018-23, and forecast to 2028). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights

The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values refer to the value generated by market players.
The European pharmaceuticals market registered revenues of $370.4 billion in 2023, representing a compound annual growth rate (CAGR) of 4.04% between 2018 and 2023.
Germany captured the largest share of the European pharmaceuticals market in 2023, accounting for a share of 23.5%, followed by France, with a share of 20.3%.

Scope

Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the pharmaceuticals market in Europe
Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Europe
Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
Add weight to presentations and pitches by understanding the future growth prospects of the Europe pharmaceuticals market with five year forecasts

Reasons to Buy

What was the size of the Europe pharmaceuticals market by value in 2023?
What will be the size of the Europe pharmaceuticals market in 2028?
What factors are affecting the strength of competition in the Europe pharmaceuticals market?
How has the market performed over the last five years?
What are the main segments that make up Europe's pharmaceuticals market?

1 Executive Summary

1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market rivalry
1.5. Competitive landscape

2 Market Overview

2.1. Market definition
2.2. Market analysis

3 Market Data

3.1. Market value

4 Market Segmentation

4.1. Geography segmentation

5 Market Outlook

5.1. Market value forecast

6 Five Forces Analysis

6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry

7 Competitive Landscape

7.1. Who are the leading players?
7.2. What are the strengths of the leading players?
7.3. What are the recent developments in the market?

8 Company Profiles

8.1. AstraZeneca Plc
8.2. Sanofi
8.3. Roche Holding AG
8.4. Novartis AG
8.5. GSK plc

9 Macroeconomic Indicators

9.1. Country data

10 Appendix

10.1. Methodology
10.2. Industry associations
10.3. Related research
10.4. About the Publisher

List of Tables

Table 1: Europe pharmaceuticals market value: $ billion, 2018-23
Table 2: Europe pharmaceuticals market geography segmentation: $ billion, 2023
Table 3: Europe pharmaceuticals market value forecast: $ billion, 2023-28
Table 4: AstraZeneca Plc: Key Facts
Table 5: AstraZeneca Plc: Annual Financial Ratios
Table 6: AstraZeneca Plc: Key Employees
Table 7: Sanofi: Key Facts
Table 8: Sanofi: Annual Financial Ratios
Table 9: Sanofi: Key Employees
Table 10: Sanofi: Key Employees Continued
Table 11: Roche Holding AG: Key Facts
Table 12: Roche Holding AG: Annual Financial Ratios
Table 13: Roche Holding AG: Key Employees
Table 14: Novartis AG: Key Facts
Table 15: Novartis AG: Annual Financial Ratios
Table 16: Novartis AG: Key Employees
Table 17: GSK plc: Key Facts
Table 18: GSK plc: Annual Financial Ratios
Table 19: GSK plc: Key Employees
Table 20: Europe Size of Population (million), 2019-23
Table 21: Europe Real GDP (constant 2010 prices, $ billion), 2019-23
Table 22: Europe GDP (current prices, $ billion), 2019-23
Table 23: Europe Inflation, 2019-23
Table 24: Europe Consumer Price Index (absolute), 2019-23
Table 25: Europe Exchange Rate, 2018-23

List of Figures

Figure 1: Europe pharmaceuticals market value: $ billion, 2018-23
Figure 2: Europe pharmaceuticals market geography segmentation: % share, by value, 2023
Figure 3: Europe pharmaceuticals market value forecast: $ billion, 2023-28
Figure 4: Forces driving competition in the pharmaceuticals market in Europe, 2023
Figure 5: Drivers of buyer power in the pharmaceuticals market in Europe, 2023
Figure 6: Drivers of supplier power in the pharmaceuticals market in Europe, 2023
Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Europe, 2023
Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in Europe, 2023
Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in Europe, 2023

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

AstraZeneca Plc
Sanofi
Roche Holding AG
Novartis AG
GSK plc

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€345EUR$350USD£287GBP
SITE LICENSE PDF	The product is a PDF.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€517EUR$525USD£430GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€689EUR$700USD£573GBP

Key Highlights

Scope

Reasons to Buy

Table of Contents

Companies Mentioned (Partial List)

Related Topics

Related Reports

Pharmaceutical Industry Outlook, 2024

Asia-Pacific Pharmaceutical Industry Outlook 2023

Autologous Cell Therapies - Global Strategic Business Report

Pharmaceuticals Top 5 Emerging Markets Industry Guide 2019-2028

Pharmaceuticals Global Group of Eight (G8) Industry Guide 2019-2028